NHS told to stop prescribing certain type of eczema treatment to children

New guidance has advised the NHS to stop offering a certain type of eczema treatment to children.

Watchdog the National Institute for Health and Care Excellence (Nice) said children should not be offered bath emollients after it had reviewed the evidence and concluded that they are not clinically or cost effective.

Evidence from the year-long Bathe trial in 2018 found that pouring emollient additives into the bath provided no additional benefit over standard eczema care. Nice said that while emollient bath additives do not make eczema worse, prescribing an “ineffective” product places “unnecessary burdens” on patients and carers in terms of obtaining and using the products.

READ MORE: DJ Graeme Park’s family flooded with support after son dies at 18

However, it said some children may benefit from bath emollients and these can still be bought over the counter if people want them.

Nice’s guidance states that children can and should continue to use emollients and/or emollient wash products instead of soaps. The new Nice draft guideline – on the diagnosis and management of atopic eczema in children under 12 – is now subject to public consultation.

Nice said the guidance brings it into line with NHS England’s advice in 2019 that emollient bath additives should not be routinely prescribed. Eczema, which causes red and itchy skin, affects around one in five children and can result in regular flare-ups or can be a continuous problem.

The Bathe trial included 482 children from 96 GP surgeries.

Read today's top stories here

READ NEXT:

The three simple habits that can help you lead a long life, according to longevity doctor

Woman unable to wee for more than a year diagnosed with rare condition that 'changed